These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1888244)

  • 1. Resistant hypertension in a tertiary care clinic.
    Yakovlevitch M; Black HR
    Arch Intern Med; 1991 Sep; 151(9):1786-92. PubMed ID: 1888244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistant hypertension revisited: a comparison of two university-based cohorts.
    Garg JP; Elliott WJ; Folker A; Izhar M; Black HR;
    Am J Hypertens; 2005 May; 18(5 Pt 1):619-26. PubMed ID: 15882544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting.
    McAdam-Marx C; Ye X; Sung JC; Brixner DI; Kahler KH
    Clin Ther; 2009 May; 31(5):1116-23. PubMed ID: 19539112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
    Cortez-Dias N; Martins S; Belo A; Fiuza M;
    Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse pressure monitoring of open antihypertensive therapy.
    Safar ME; Vaisse B; Blacher J; Rudnichi A; Mourad JJ
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1088-94. PubMed ID: 15607613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistant arterial hypertension].
    Bobrie G; Coville P
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1183-5. PubMed ID: 8572870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pharmacist intervention on control of resistant hypertension.
    Morse GD; Douglas JB; Upton JH; Rodgers S; Gal P
    Am J Hosp Pharm; 1986 Apr; 43(4):905-9. PubMed ID: 3706334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective review of the medical records of cardiology hospital outpatient clinics with the aim of determining the therapeutic approach to patients suffering from high blood pressure and/or dyslipidemia.
    Rato Q; Cardoso AA
    Rev Port Cardiol; 2006 Oct; 25(10):889-905. PubMed ID: 17190239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the prevalence and treatment of hypertension in Halifax County from 1985 to 1995.
    Wolf HK; Andreou P; Bata IR; Comeau DG; Gregor RD; Kephart G; MacLean DR; Sketris I
    CMAJ; 1999 Sep; 161(6):699-704. PubMed ID: 10513276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.